| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 31349-29-8 | 4-Pyrimidinecarboxaldehyde,1,2,3,6-tetrahydro-5-[(2-hydroxy-5-nitrophenyl)methyl]-6-oxo-2-thioxo-; Orotaldehyde,5-(5-nitrosalicyl)-2-thio- (8CI); NSC 153755 |  | C12H9N3O5S | 詳情 | 供應(yīng)商 | |
| 141078-94-6 | 4H-1,2,4-Triazole,3-(4-fluorophenyl)-4-(4-methylphenyl)-5-(phenoxymethyl)-; 4H-1,2,4-Triazole, 3-(4-fluorophenyl)-4-(4-methylphenyl)-5-(phenoxymet hyl)- |  | C22H18FN3O | 詳情 | 供應(yīng)商 | |
| 110605-02-2 | 4(3H)-Quinazolinone,3-[[[2-(4-chlorophenyl)diazenyl]phenylmethylene]amino]-2-methyl-; 4(3H)-Quinazolinone,3-[[[(4-chlorophenyl)azo]phenylmethylene]amino]-2-methyl- (9CI) |  | C22H16ClN5O | 詳情 | 供應(yīng)商 | |
| 61326-04-3 | 4H-Thieno[3,4-b][1,5]benzodiazepine,6,7-dichloro-10-(1-piperazinyl)-; 4H-Thieno3,4-b1,5benzodiazepine, 6,7-dichloro-10-(1-piperazinyl)- |  | C15H14Cl2N4S | 詳情 | 供應(yīng)商 | |
| 33017-98-0 | 4(3H)-Quinazolinone,5,6,7,8-tetrahydro-2-(4-phenyl-1-piperazinyl)-; 4-Quinazolinol,5,6,7,8-tetrahydro-2-(4-phenyl-1-piperazinyl)- (8CI) |  | C18H22N4O | 詳情 | 供應(yīng)商 | |
| 108674-21-1 | 4(3H)-Quinazolinone,6,8-dibromo-3-(2-methoxyphenyl)-2-[[(1-methylpropyl)sulfonyl]methyl]- |  | C20H20Br2N2O4S | 詳情 | 供應(yīng)商 | |
| 15932-34-0 | 4H-Pyrazino[3,2,1-jk]carbazole,5,6-dihydro-8-methyl-, hydrochloride (1:1); 4H-Pyrazino[3,2,1-jk]carbazole,5,6-dihydro-8-methyl-, monohydrochloride (8CI,9CI) |  | C15H15ClN2 | 詳情 | 供應(yīng)商 | |
| 6460-75-9 | 4-Morpholinepentanoicacid, g-(benzoylamino)-d-oxo-; 4-Morpholinepentanoicacid, g-(benzoylamino)-d-oxo-, (?à)-; 4-Morpholinevaleric acid, g-benzamido-d-oxo-, DL- (8CI) |  | C16H20N2O5 | 詳情 | 供應(yīng)商 | |
| 100098-83-7 | 4H-1,3-Oxazine,5,6-dihydro-4,4,6-trimethyl-2-[2-(1-naphthalenyl)ethenyl]-, hydrochloride, (E)-(9CI); 4,4,6-trimethyl-2-[(E)-2-naphthalen-1-ylethenyl]-5,6-dihydro-1,3-oxazi ne hydrochloride |  | C19H22ClNO | 詳情 | 供應(yīng)商 | |
| 165121-46-0 | 4-Acridinecarboxamide,N-[4-(aminosulfonyl)phenyl]-; NSC 640403; NSC 644043 |  | C20H15N3O3S | 詳情 | 供應(yīng)商 | |
| 80841-47-0 | 4-Acridinecarboxamide,9-[[2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino]-N,5-dimethyl-; Asulacrine; CI 921; SN 21407; amsalog |  | C24H24N4O4S | 詳情 | 供應(yīng)商 | |
| 6320-49-6 | 4-Thiazolidinone,5-[(5-chloro-2-hydroxyphenyl)methylene]-2-thioxo-; Rhodanine,5-(5-chlorosalicylidene)- (5CI); NSC 31201 |  | C10H6ClNO2S2 | 詳情 | 供應(yīng)商 | |
| 117047-25-3 | 4H-Imidazo[1,5-a][1,4]benzodiazepine-3-carboxylicacid, 8-chloro-6-phenyl-, ethyl ester; Ethyl8-chloro-6-phenyl-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate; Ro15-8670 |  | C20H16ClN3O2 | 詳情 | 供應(yīng)商 | |
| 23522-59-0 | 4-Thiazolidinone,5-butyl-3-(4-chlorophenyl)-2-thioxo-; Rhodanine,5-butyl-3-(p-chlorophenyl)- (7CI,8CI) |  | C13H14ClNOS2 | 詳情 | 供應(yīng)商 | |
| 103980-62-7 | 4(3H)-Pyrimidinone,5-ethoxy-2-ethyl-; 4(1H)-Pyrimidinone,5-ethoxy-2-ethyl- (9CI) |  | C8H12N2O2 | 詳情 | 供應(yīng)商 | |
| 284681-95-4 | 4-Pyrimidinamine,2-(butylthio)-6-(phenylthio)- |  | C14H17N3S2 | 詳情 | 供應(yīng)商 | |
| 158991-19-6 | 4H-Furo[2,3-b]pyran-4-one,2,3-dihydro-6-(4-hydroxyphenyl)-2,3,3-trimethyl-, (-)-; Hyperbrasilone |  | C16H16O4 | 詳情 | 供應(yīng)商 | |
| 73356-67-9 | 4H-Furo[3,2-b]indole-2-carboxamide,4-methyl-N-[3-(1-piperidinyl)propyl]-6-(trifluoromethyl)-; FI 302 |  | C21H24F3N3O2 | 詳情 | 供應(yīng)商 | |
| 3198-41-2 | 4-Acridinamine,5,6,7,8-tetrahydro-; Acridine,5-amino-1,2,3,4-tetrahydro- (7CI,8CI); 1,2,3,4-Tetrahydro-5-aminoacridine |  | C13H14N2 | 詳情 | 供應(yīng)商 | |
| 2308-51-2 | 4H-Pyran-4-one,3,5-dihydroxy-2-(hydroxymethyl)-; 3-Hydroxykojicacid; Kojic acid, 3-hydroxy-; Pyrone III |  | C6H6O5 | 詳情 | 供應(yīng)商 | |